Continuous Glucose Monitoring: Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management
Faculty Disclosures
Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Bayer
Speaker’s Bureau: Eli Lilly, NovoNordisk
Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose:
Speaker’s Bureau: Novo Nordisk, Inc.
Other Support: Advanced Practitioner Advisory Board- Novo Nordisk, Inc.
This activity is supported by an independent educational grant from Abbott Diabetes Care Inc.

Where's the Patient's Voice in Evidence-based Treatment & Research? | Pharmacist and Physician Opioid Collaborative
1:00:11

Pharmacists Answering the call | Pharmacy Podcast Nation
56:55

Ja'Miera Stuart PharmD | Brighter Horizons
19:30